HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Homoeopathy blasted by legislators in Germany

This article was originally published in OTC Bulletin & The Rose Sheet

Executive Summary

Germany should revoke the ‘medicinal’ status it applies to homoeopathic products so they no longer qualify for reimbursement by the country’s statutory health insurance system, leading representatives of Germany’s legislature have argued.

You may also be interested in...



German Industry Tries To Nip Homeopathy Debate In The Bud As France Decides In Favour Of De-Reimbursement

As France decides to de-reimburse homeopathic medicines, discussions about whether this should be applied to Germany are being re-opened by politicians and high-profile representatives from the country's statutory health insurance system. Industry has responded by saying "no" to de-reimbursement, as the German system allows consumers to choose between insurers based on their views of homeopathy. 

Pharmaceutical Society Of Australia Wants Pharmacy To ‘Draw A Line In The Sand’ And Stop Supplying Homeopathy

The Pharmaceutical Society of Australia has called on the country's pharmacy banner and buying groups to help remove homeopathic products from the shelves of Australian community pharmacies, thereby joining an international chorus of voices that has emerged over the last year questioning the efficacy of these treatments.

French Public Throw Support Behind Homoeopathic Reimbursement

Homeopathy continues to come under the spotlight in Europe, with France the latest country to examine the value of reimbursing such products.

Topics

UsernamePublicRestriction

Register

RS121899

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel